HomeBIAF • NASDAQ
add
bioAffinity Technologies Inc
Previous close
$0.54
Day range
$0.46 - $0.53
Year range
$0.24 - $3.15
Market cap
9.13M USD
Avg Volume
19.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.21M | -0.26% |
Operating expense | 3.59M | 24.25% |
Net income | -2.97M | -25.02% |
Net profit margin | -134.40 | -25.35% |
Earnings per share | -0.21 | — |
EBITDA | -2.79M | -27.32% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.11M | -60.83% |
Total assets | 6.51M | -20.77% |
Total liabilities | 3.91M | 16.20% |
Total equity | 2.60M | — |
Shares outstanding | 17.91M | — |
Price to book | 3.18 | — |
Return on assets | -112.76% | — |
Return on capital | -164.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.97M | -25.02% |
Cash from operations | -1.68M | -3.77% |
Cash from investing | -1.00 | -100.01% |
Cash from financing | 2.03M | 2,488.86% |
Net change in cash | 348.71K | 120.66% |
Free cash flow | -567.94K | -24.80% |
About
Founded
2014
Headquarters
Website
Employees
57
